YINGCHI New Study | 4 days for rapid onset, 6 months of sustained relief! “Sequential Dual-Target” accelerated rTMS: A new treatment protocol for depression
Major Depressive Disorder (MDD) is the leading cause of disability worldwide. Traditional medications and psychotherapy have limited efficacy in some patients. Although repetitive transcranial magnetic stimulation (rTMS) has been approved for MDD, the standard protocol has drawbacks including long treatment duration and slow onset of action. To improve treatment efficiency, reduce costs, and increase accessibility,... Read more
